Welcome to the latest edition of our Healthcare & Life Sciences Market Update, in which we explore the evolving landscape of investment trends, regulatory challenges, and strategic opportunities shaping the global market....more
Welcome to the first edition of our European Healthcare & Life Sciences Market Update, a new report summarising key emerging trends, opportunities, and challenges facing the market in 2022. During the last 12 months, the...more
2/10/2022
/ Clinical Trials ,
Digital Health ,
EU ,
EU Clinical Trials Regulation (CTR) ,
Health Care Providers ,
Joint Venture ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Regulatory Agenda ,
Regulatory Standards ,
UK ,
Venture Capital
Subcontractors, security, and audit and termination rights will require special consideration under forthcoming EBA outsourcing guidelines.
Recent growth in divestiture and carve-out deals in the M&A landscape, including...more
10/29/2019
/ Acquisitions ,
Banking Sector ,
Carve Out Provisions ,
Contract Terms ,
Divestiture ,
European Banking Authority (EBA) ,
Exit Strategies ,
Financial Institutions ,
Mergers ,
Outsourcing ,
Regulatory Standards ,
Subcontractors ,
Third-Party Service Provider ,
Transitional Arrangements